Immunogenicity 14981
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
CYP4F2
Transcript ID
uc010xou.1
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (190 aa)
MLTPA
1
FHFNI
6
LKPYM
11
KIFNE
16
SVNIM
21
HAKWQ
26
LLASE
31
GSACL
36
DMFEH
41
ISLMT
46
LDSLQ
51
KCVFS
56
FDSHC
61
QEKPS
66
EYIAA
71
ILELS
76
ALVSK
81
RHHEI
86
LLHID
91
FLYYL
96
TPDGQ
101
RFRRA
106
CRLVH
111
DFTDA
116
VIQER
121
RRTLP
126
SQGVD
131
DFLQA
136
KAKSK
141
TLDFI
146
DVLLL
151
SKAMT
156
PRPVV
161
SPGSC
166
TTLQS
171
TQNTR
176
SAAGR
181
RCKNF
186
Mutation Information
DNA mutation:
None
Peptide Range:
91 ~ 115
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"LLHIDFLYYLTPDGQRFRRACRLVH
||||||||||||.||||||||||||
Mutant:
LLHIDFLYYLTPNGQRFRRACRLVH"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) CYP4F2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay